Resources
Search Resources

Unsafe Drugs & Medical Devices

Page 1 of 212
  • Da Vinci Surgical Robot Subject of FDA ProbeJuly 13th, 2015

    Last summer we published a post about growing numbers of injuries sustained by patients during surgeries with the da Vinci surgical robot system, e.g. “tears and burns, to blood vessels, intestines, uterus and vaginal cuff dehiscence.” Complaints have also been leveled against the electrical arms …

  • Markups on Brand-Name Medication Strain Hospital BudgetsJune 17th, 2015

    A revelatory article in a recent edition of the Wall Street Journal sheds light on one of the most important factors influencing prescription drug pricing: their brand labels. The authors of the story, which ran with the headline, “Pharmaceutical Companies Buy Rivals’ Drugs, Then Jack …

  • Doctors, Attorneys Allege Low Testosterone “Disease Mongering”May 13th, 2015

    When we first covered the alleged link between testosterone drug therapy and cardiovascular problems–particularly in older men–last June, there were about 50 such cases pending across the country. Now there are at least 1,500, and that number is growing every week. Reports do not vary …

  • Feldman Shepherd Attorney Sues Bayer’s MiraLax for Kidney FailureMay 6th, 2015

    Since at least 2009, researchers have been aware that MiraLax, an over-the-counter laxative manufactured by Bayer Corp., is not safe for patients who suffer from kidney disease. But this did not stop the company and is affiliates from allowing the drug to be taken by …

  • 5 Hospitals Report Antibiotic-Resistant Bacterial OutbreaksApril 8th, 2015

    Having covered the dangers that hospitals pose (on several occasions) and the previousfailures of the FDA to keep consumers safe (again, on several occasions), it will come as no surprise to readers to learn that the topic of this post brings the two together. Several …

  • Many Generic Herbal Supplements Not Herbal At AllMarch 18th, 2015

    Health experts have long criticized store-brand herbal supplements. And finally they have been vindicated. The Attorney General’s office recently oversaw testing on products from nationwide chains like Walmart, Walgreens, Target, and GNC, finding that only a very small minority contained any of the ingredients listed …

  • Antidepressants, Sleep Aids, and Allergy Drugs Linked to Alzheimer’s DiseaseMarch 4th, 2015

    For many years, consumers have taken Benadryl as a sleep aid, assuming that it is a safe and non-habit forming solution for occasional insomnia. A recent study, however, led by Dr. Shelly Gray of the University of Washington School of Pharmacy and published in JAMA …

  • Drug Companies Spend Millions Marketing Redundant and Potentially Dangerous TreatmentsFebruary 4th, 2015

    The investigative journalism website ProPublica, in conjunction with the New York Times medical blog The Upshot, recently published an article analyzing drug companies’ spending over the past five months in order to ascertain what drugs and medical devices they were promoting most heavily. The answer, it …

  • Further FDA Failures: Diabetes MedicationsJanuary 28th, 2015

    When it comes to regulation, there are many areas in which the FDA could improve its practices–compounding pharmacies, energy drinks, herbal dietary products, generic drugs,testosterone supplements, plastic water bottles, and cancer treatments–but we can now add diabetes medication like Januvia, Byetta, and Victoza to this list …

  • Pharmacy Linked to Fungal Meningitis Outbreak Faces Criminal ChargesJanuary 7th, 2015

    Back in October 2012, this blog began covering a fungal meningitis outbreak originating in Massachusetts that eventually killed sixty-four people and injured over 750 more across twenty states. Authorities traced the debilitating outbreak to the New England Compounding Center, a pharmaceutical company that provided personalized …

  • Generic Drugmaker Makes Potentially Dangerous Product, Sues FDA for Slowing Its SaleDecember 17th, 2014

    This blog has been covering issues related to generic drugs–warning labels, FDA oversight, and legal immunity–for more than a year, but this industry is nothing if not persistent. One of the largest manufacturers of generic pharmaceuticals in the world–Ranbaxy Laboratories, with net revenue of $2 …

  • $15 Million Herbalife Settlement Raises Questions about Dietary Supplement RegulationDecember 10th, 2014

    In the past few months, this blog has explored ways in which class action lawsuits and FDA regulation affect the lives of everyday Americans. Today we will discuss the corporation Herbalife–which sells “nutrition, weight-management, energy and fitness, and personal care products”–in a story that combines …

  • After Approval, FDA Decides to Give Low-Testosterone Drugs a Second LookSeptember 17th, 2014

    This past June, in an article about a potential link between testosterone treatment and cardiovascular problems, we explained that the FDA had (after about ten years of urging by researchers) decided to launch an investigation into the matter. It turns out that it only took a …

  • Testosterone Treatment Linked to Cardiovascular ProblemsJune 25th, 2014

    Over the past decade, according to the New York Times, testosterone replacement therapy (a form of hormone replacement) has quadrupled among men aged 40 and older. By 2011, about one in 25 men in their 60s was on a testosterone replacement plan. While this figure …

  • Parallel Claims Alter Medical Products Liability ClaimsApril 2nd, 2014

    The last week in February, Michael Walsh published an article in the New Jersey Law Journal claiming that courts are “relegating failure-to-warn claims, the decades-old staple of medical products liability, to the trash bin of tort jurisprudence” in favor of parallel claims. Walsh points to three …

  • Pennsylvania Supreme Court Stops Immunizing Big Pharma for Harmful ProductsJanuary 29th, 2014

    The seemingly never-ending products liability case in Pennsylvania’s Supreme Court Lance v. Wyeth has finally drawn to a close after more than three years of arguments and appeals. This case involves Catherine Ruth Lance, whose family argues that Wyeth (a pharmaceutical company) was negligent in …

  • Generic Drug Industry Still Largely UncheckedJanuary 22nd, 2014

    In the past few months, this blog has addressed issues concerning the safety of generic drugs. In July we published an article about the Supreme Court protecting manufacturers of generics in cases in which victims were harmed due to inadequate warning labels. Fortunately, the FDA …

  • Compounding Pharmacies Come Closer to RegulationJanuary 8th, 2014

    About one year ago, a fungal meningitis outbreak in New England affected nearly eight hundred individuals in twenty states, claiming over sixty lives in the process. The source of these infections was the New England Compounding Center (NECC) in Massachusetts, which was an active distributor …

  • Health Canada Warns Doctors Cancer Drug Xeloda May Cause Stevens-Johnson SyndromeDecember 11th, 2013

    Over a year ago, this blog published an article about the dangers of Stevens-Johnson syndrome, a serious condition that causes a dark red rash to appear on the skin. Health Canada, Canada’s counterpart to the United States’ Food and Drug Administration (FDA), recently sent an …

  • FDA Proposes New Generic Drug Warning Label RegulationsNovember 27th, 2013

    It might surprise one to learn that 80 percent of pharmaceuticals currently prescribed in the United States are generic. But would it be surprising to know that brand-name drug manufacturers and those that make generic drugs were not always subject to the same rules? Earlier …

  • Several New Risks Emerge For Women Taking Hormone Replacement DrugsOctober 16th, 2013

    Hormone replacement therapy (HRT) drugs are a popular therapeutic option for women going through menopause. The idea is that replacing the body’s diminishing supply of estrogen and progesterone may alleviate discomfort, prolong life, or even delay or reduce the onset of dementia. Three recently published …

  • FDA Delays on Sutent Side Effects WarningSeptember 25th, 2013

    Sutentis a drug manufactured by Pfizer is prescribed by doctors to treat cancer of the pancreas, stomach, bowels, and kidney. Recently, however, Sutent has been linked to cases of the potentially fatal Stevens-Johnson syndrome and its more severe form, toxic epidermal necrolysis. For this reason, …

  • Doctors Receiving Kickbacks May Be Persuaded to PrescribeAugust 21st, 2013

    The blog aboutlawsuits.com recently published a blog post by Irvin Jackson about a new study that deals with doctors receiving “kickbacks” from pharmaceutical companies or drug representatives for prescribing a given medication. Scholars at the Rady School of Management at University of California, San Diego …

  • British Study Reveals Role of Technology in Surgical ErrorsAugust 14th, 2013

    The British Medical Journal: Quality and Safety recently published a study evaluating the role equipment and technology play in surgical mistakes. The article appeared on July 25 on the journal’s web site and is titled, “Surgical technology and operating-room safety failures: a systematic review of …

  • NuvaRing Plaintiffs Will Soon Get Their Day in CourtAugust 7th, 2013

    Last July, we posted our first article on the potential dangers of the NuvaRing method of birth control (manufactured by Merck) a vaginal ring that patients wear for a period of about three weeks, during which time it slowly releases hormones into the bloodstream. It …